MY168931A - Therapeutic agent for arthrosis - Google Patents
Therapeutic agent for arthrosisInfo
- Publication number
- MY168931A MY168931A MYPI2014701211A MYPI2014701211A MY168931A MY 168931 A MY168931 A MY 168931A MY PI2014701211 A MYPI2014701211 A MY PI2014701211A MY PI2014701211 A MYPI2014701211 A MY PI2014701211A MY 168931 A MY168931 A MY 168931A
- Authority
- MY
- Malaysia
- Prior art keywords
- arthrosis
- therapeutic agent
- provides
- phosphatidic acid
- effects
- Prior art date
Links
- 201000008482 osteoarthritis Diseases 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 3
- 229940124597 therapeutic agent Drugs 0.000 title abstract 3
- PUPWWTUVIZOPTB-KTKRTIGZSA-N (2-hydroxy-2-oxo-1,2$l^{5}-oxaphospholan-4-yl)methyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC1COP(O)(=O)C1 PUPWWTUVIZOPTB-KTKRTIGZSA-N 0.000 abstract 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000001188 articular cartilage Anatomy 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011247047 | 2011-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY168931A true MY168931A (en) | 2019-01-09 |
Family
ID=48289788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2014701211A MY168931A (en) | 2011-11-11 | 2012-10-12 | Therapeutic agent for arthrosis |
Country Status (15)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI758777B (zh) * | 2014-08-12 | 2022-03-21 | 日商大塚化學股份有限公司 | 環狀膦酸鈉鹽之結晶及其製造方法 |
| JP6727596B1 (ja) | 2019-11-22 | 2020-07-22 | 国立大学法人お茶の水女子大学 | カルバリゾホスファチジン酸 |
| US11958876B2 (en) | 2019-12-23 | 2024-04-16 | Otsuka Chemical Co., Ltd. | Carbacyclic phosphatidic acid compound |
| JP7736256B2 (ja) * | 2020-11-13 | 2025-09-09 | 株式会社マツモト交商 | 環状ホスファチジン酸含有組成物及び美容方法 |
| EP4252756A4 (en) | 2020-11-26 | 2024-10-16 | Sansho Co., Ltd. | THERAPEUTIC AGENT FOR PULMONARY FIBROSIS |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2700350B2 (ja) | 1990-04-20 | 1998-01-21 | 小糸工業株式会社 | 車両感知器 |
| JP3195833B2 (ja) | 1991-09-30 | 2001-08-06 | きみ子 室伏 | 新規生理活性物質及びその製造法 |
| JPH07149772A (ja) * | 1993-11-26 | 1995-06-13 | Sagami Chem Res Center | タンパク質リン酸化酵素ｃの活性促進剤 |
| JPH07258278A (ja) | 1994-03-18 | 1995-10-09 | Sagami Chem Res Center | １−Ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするＤＮＡポリメラーゼαの阻害剤 |
| JPH0925235A (ja) | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | １−ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするがん転移抑制剤 |
| JP2001178489A (ja) | 1999-12-24 | 2001-07-03 | Kimiko Murofushi | 環状ホスファチジン酸の製造法 |
| JP4815063B2 (ja) * | 2001-04-13 | 2011-11-16 | きみ子 室伏 | 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び／又は生存の促進のための薬剤 |
| JP4836345B2 (ja) * | 2001-04-13 | 2011-12-14 | きみ子 室伏 | 環状ホスファチジン酸誘導体を含む神経細胞の生存促進剤 |
| EP1402894B1 (en) * | 2001-05-21 | 2007-12-26 | Kimiko Murofushi | Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives |
| JP4162927B2 (ja) * | 2002-06-11 | 2008-10-08 | きみ子 室伏 | カルバ環状ホスファチジン酸誘導体 |
| RU2240131C1 (ru) * | 2003-04-04 | 2004-11-20 | Аладьев Сергей Иванович | Средство "артровит" для профилактики и лечения артритов и артрозов |
| AU2004229467B2 (en) * | 2003-04-11 | 2007-01-25 | The University Of Tennessee Research Foundation | Lysophosphatidic acid analogs and inhibition of neointima formation |
| EP1848710B1 (en) | 2005-02-16 | 2013-10-16 | Merck Sharp & Dohme Corp. | Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| KR20090097943A (ko) * | 2006-12-28 | 2009-09-16 | 오짜노미즈 유니버시티 | 환상 포스파티딘산 유도체를 포함하는 진통제 |
| JP2010189315A (ja) * | 2009-02-18 | 2010-09-02 | Unitika Ltd | 関節軟骨損傷治癒促進剤及びそれを含有する飲食品 |
-
2012
- 2012-10-12 WO PCT/JP2012/076478 patent/WO2013069404A1/ja not_active Ceased
- 2012-10-12 AU AU2012337087A patent/AU2012337087B2/en active Active
- 2012-10-12 SG SG11201402226PA patent/SG11201402226PA/en unknown
- 2012-10-12 RU RU2014123690A patent/RU2646457C2/ru active
- 2012-10-12 EP EP12847890.6A patent/EP2803359B1/en active Active
- 2012-10-12 MY MYPI2014701211A patent/MY168931A/en unknown
- 2012-10-12 CN CN201280055135.7A patent/CN103906519B/zh active Active
- 2012-10-12 US US14/357,089 patent/US9085593B2/en active Active
- 2012-10-12 BR BR112014011315A patent/BR112014011315B8/pt active IP Right Grant
- 2012-10-12 CA CA2855660A patent/CA2855660C/en active Active
- 2012-10-12 KR KR1020147015608A patent/KR101953181B1/ko active Active
- 2012-10-12 IN IN4222CHN2014 patent/IN2014CN04222A/en unknown
- 2012-10-12 JP JP2013542900A patent/JP5465815B2/ja active Active
- 2012-10-12 PH PH1/2014/501058A patent/PH12014501058B1/en unknown
- 2012-10-12 ES ES12847890.6T patent/ES2634008T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2855660A1 (en) | 2013-05-16 |
| BR112014011315B8 (pt) | 2020-09-15 |
| JP5465815B2 (ja) | 2014-04-09 |
| CN103906519B (zh) | 2017-10-10 |
| CN103906519A (zh) | 2014-07-02 |
| IN2014CN04222A (cg-RX-API-DMAC7.html) | 2015-07-17 |
| KR101953181B1 (ko) | 2019-02-28 |
| EP2803359B1 (en) | 2017-04-19 |
| RU2646457C2 (ru) | 2018-03-05 |
| BR112014011315B1 (pt) | 2020-03-03 |
| NZ624870A (en) | 2016-01-29 |
| PH12014501058B1 (en) | 2019-11-08 |
| US9085593B2 (en) | 2015-07-21 |
| US20140309194A1 (en) | 2014-10-16 |
| RU2014123690A (ru) | 2015-12-20 |
| CA2855660C (en) | 2019-04-16 |
| WO2013069404A1 (ja) | 2013-05-16 |
| SG11201402226PA (en) | 2014-10-30 |
| PH12014501058A1 (en) | 2014-06-23 |
| AU2012337087A1 (en) | 2014-06-05 |
| AU2012337087B2 (en) | 2016-11-17 |
| KR20140098778A (ko) | 2014-08-08 |
| HK1199406A1 (en) | 2015-07-03 |
| ES2634008T3 (es) | 2017-09-26 |
| BR112014011315A2 (pt) | 2017-05-09 |
| JPWO2013069404A1 (ja) | 2015-04-02 |
| EP2803359A4 (en) | 2015-12-16 |
| EP2803359A1 (en) | 2014-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201813877T4 (tr) | Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler. | |
| PH12017501306A1 (en) | Inhibitors of histone demethylases | |
| PH12014502704A1 (en) | Compounds and compositions for modulating egfr activity | |
| PH12012502452A1 (en) | Vectors and sequences for the treatment of diseases | |
| AU2013225533A8 (en) | Amido spirocyclic amide and sulfonamide derivatives | |
| HK1204908A1 (en) | Advanced methods, techniques, devices, and systems for cruciate retaining knee implants | |
| MY199894A (en) | Prmt5 inhibitors and uses thereof | |
| PH12014501273A1 (en) | Intranasal dexmedetomidine compositions and methods of use thereof | |
| MX2014010406A (es) | Compuestos para tratar atrofia muscular espinal. | |
| JO3156B1 (ar) | ايميدازولات مدمجة والتركيبات التي تشملها لعلاج الأمراض الطفيلية على مثال الملاريا | |
| HK1209159A1 (en) | Methods of decellularizing bone | |
| WO2013003827A3 (en) | Macrogol 15 hydroxystearate formulations | |
| WO2011113060A3 (en) | Antiviral compounds and methods of use thereof | |
| IN2014KN02620A (cg-RX-API-DMAC7.html) | ||
| WO2012106427A3 (en) | Methods for treating diabetic foot ulcers | |
| MY168931A (en) | Therapeutic agent for arthrosis | |
| MX364934B (es) | Agente para prevenir y/o tratar dolor neuropático periférico causado por fármaco contra el cáncer. | |
| MX2014009892A (es) | Combinaciones de inhibidor de histona desacetilasa y pazopanib y usos de las mismas. | |
| NZ712341A (en) | A crystalline form of an anxiolytic compound | |
| MY165088A (en) | Pharmaceutical compositions comprising alisporivir | |
| MX2011006721A (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
| IN2014MN01382A (cg-RX-API-DMAC7.html) | ||
| IN2014DN07410A (cg-RX-API-DMAC7.html) | ||
| SG178938A1 (en) | Therapeutic agent for chronic pain | |
| WO2011042077A8 (de) | Transdermale therapeutische systeme enthaltend 4-n-butylresorcin |